Lonza Clonetics human intestinal myofibroblasts

Friday, 04 February, 2011 | Supplied by: Lonza Australia Pty Ltd

Clonetics human intestinal myofibroblasts, cryopreserved at passage 2 with 500,000 cells per vial, are available. The recommended media kit is SMGM-2 smooth muscle growth media.

H-InMyoFibs share phenotypic characteristics of both fibroblasts and smooth muscle cells but do not express smooth muscle markers such as smoothelin, caldesmon or (in the normal colon and small intestine) desmin.

H-InMyoFibs play a fundamental role in growth and development of intestine, immunology, inflammation, fibrosis, water and electrolyte transport, contraction and wound healing.

They are a useful tool in general gastrointestinal research as well as: absorption studies and toxicology (oral medications), inflammation, fibrosis, water and electrolyte transport, contraction and peristalsis, wound healing, neoplasia and intestinal polyp formation, Crohn’s disease, toxicology and cytotoxicity and gene expression.

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

AdipoGen Life Sciences tubulin products for neurodegeneration research

AdipoGen Life Sciences offers a broad range of microtubule research solutions. This includes...

SYnAbs monoclonal antibodies

SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex...

Merck VirusExpress Lentiviral Production Platform

The platform helps to overcome lentiviral production challenges and can reduce process...

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd